Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Clinical trial NCT05583175 · UNKNOWN

Trial details

NCT number: NCT05583175
Sponsor: Xianmin Song, MD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute MDS Hematopoietic Stem Cell Transplantation Myeloid Malignancy

Start date: 2022-11-01
Primary completion: 2024-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.